We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sigma® Life Science Creates World’s First Knock-in Rats using Zinc Finger Nuclease Technology

News   Dec 14, 2010

 
Sigma® Life Science Creates World’s First Knock-in Rats using Zinc Finger Nuclease Technology
 
 
 

RELATED ARTICLES

Hindering Melanoma Metastasis with FDA-approved Drug

News

An FDA-approved drug has been identified that, when used with surgery, hampers metastasis in an animal model. Originally developed and approved ~65 years ago to control blood pressure, the medication resperine also prevents what are known as tumor-derived extracellular vesicles from fusing to healthy cells and sharing their cargo of disease-promoting molecules.

READ MORE

Stroke Drug May Prevent Alzheimer's Disease

News

Researchers have discovered that a drug currently being developed to treat stroke patients could also prevent Alzheimer's disease.

READ MORE

Converting Cancer Cells to Fat Cells to Stop Cancer’s Spread

News

A method for fooling breast cancer cells into fat cells has been discovered by researchers from the University of Basel.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE